double-blind, randomized placebo-controlled trial examining the effect of MitoQ on myocardial energetics in patients with dilated cardiomyopathy.
Halliday BP., Owen R., Ragavan A., Smith KL., Statton B., Berry A., Kasiakogias A., Tsoumani Z., Shanmuganathan M., Dungu JN., de Marvao A., Tayal U., Ware JS., O'Regan DP., Pennell DJ., Cleland JGF., Prasad SK., Gregson J., Murphy MP., Rider OJ., Valkovič L.